The FDA approved the poly ADP ribose polymerase (PARP) inhibitor in June 2023 in combination with enzalutamide for men with ...

Stealth received the FDA's so-called 'complete response letter' after a 16.5-month review, during which the FDA extended its ...

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical intervention,” the administration said. The FDA reported finding 209 cases ...

Officials with the US Food and Drug Administration say they have cleared the first-ever blood test that will help in diagnosing cases of Alzheimer’s disease.

HistoSonics, announced today that its Edison Histotripsy System for the non-invasive destruction of liver tumours has been ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Cardiol Therapeutics would like to take this opportunity to thank Michael Willner for his service as a Board member since September 2021 and for his valuable contributions to the Company's development ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

But some insurers and employers may decide to still cover the shots regardless of the new recommendations, said Jen Kates, a ...

The Consumer Protection Agency (CPA) has cautioned the public over the influx of fake and substandard baby diapers on the ...

Merck (MRK) stock falls as the company withdraws U.S. marketing application for lung cancer therapy HER3-DXd developed with ...

BOSTON, May 29, 2025 /PRNewswire/ -- On May 20, Medicilon Preclinical Research (Shanghai) LLC ("Medicilon") announces that it has successfully passed an on-site inspection by the FDA. The company ...